Detalhe da pesquisa
1.
Risk stratification of intermediate-risk acute myeloid leukemia: integrative analysis of a multitude of gene mutation and gene expression markers.
Blood;
118(4): 1069-76, 2011 Jul 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21596848
2.
Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity.
Blood;
117(8): 2469-75, 2011 Feb 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21177436
3.
Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling.
Haematologica;
94(1): 131-4, 2009 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18838472
4.
Prognostically useful gene-expression profiles in acute myeloid leukemia.
N Engl J Med;
350(16): 1617-28, 2004 Apr 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15084694
5.
High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated.
Blood;
111(8): 4329-37, 2008 Apr 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18272813
6.
Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance.
Blood;
106(12): 3747-54, 2005 Dec 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16109776